Target therapies in melanoma, from metastatic to adjuvant setting
At Immunotherapy and Melanoma Bridge meeting we interviewed Paolo Ascierto and Claus Garbe.
BRIDGE
-
What’s new in melanoma treatment?
Omid Hamid
Chief of Translational Research and Immunotherapy
Director of Melanoma Center
The Angeles Clinic and Research Institute -
Pros and cons of sequencing and combinations in Immunotherapy
Robert L. Ferris
Director UPMC Hillman Cancer Center
Melanoma treatment: past, present and future…
Igor Puzanov
Roswell Park Comprehensive Cancer Center
Jacobs School of Medicine, University at Buffalo -
New frontiers of immunotherapy in non-melanoma skin cancers
We interviewed Reinhard Dummer and Paolo Ascierto during Immunotherapy Bridge 2018.
Tumori cutanei non melanoma: è iniziata l’era degli anti PD-1?
Gli interventi di Paolo Ascierto e Dirk Schadendorf al simposio “Immunotherapy in non-melanoma skin cancer: updates and new perspective”.